Shire is weighing options for sweetening its multi-billion-dollar, all-stock offer for U.S. biotechnology firm Baxalta Inc. by putting cash into shareholders’ hands sooner, said people familiar with the matter.
from WSJ.com: US Business http://ift.tt/1VWo56N
via IFTTT
No comments:
Post a Comment